Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · IEX Real-Time Price · USD
1.195
+0.075 (6.70%)
At close: Jul 2, 2024, 4:00 PM
1.218
+0.023 (1.92%)
After-hours: Jul 2, 2024, 7:28 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $21.57 million as of July 2, 2024. Its market cap has decreased by -61.13% in one year.
Market Cap
21.57M
Enterprise Value
9.80M
1-Year Change
-61.13%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $21.57M, a decrease of -82.69%. That is a compound annual growth rate of -41.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 20.20M | -52.13% |
| Dec 29, 2023 | 42.20M | 13.44% |
| Dec 30, 2022 | 37.20M | -42.33% |
| Dec 31, 2021 | 64.50M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 21.00M |
| Oncternal Therapeutics | 20.76M |
| Akso Health Group | 20.35M |
| Unicycive Therapeutics | 20.31M |
| American Shared Hospital Services | 20.29M |
| ATI Physical Therapy | 20.13M |
| Viracta Therapeutics | 20.03M |
| TRxADE HEALTH | 20.00M |